Visionary Wealth Advisors bought a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 33,945 shares of the company’s stock, valued at approximately $4,362,000.
Other large investors also recently added to or reduced their stakes in the company. Barrow Hanley Mewhinney & Strauss LLC purchased a new position in shares of Merck KGaA during the second quarter worth $942,087,000. Bank of Nova Scotia purchased a new stake in shares of Merck KGaA in the 2nd quarter valued at $281,696,000. Danske Bank A S purchased a new stake in shares of Merck KGaA in the 2nd quarter valued at $276,535,000. Cullen Capital Management LLC acquired a new position in Merck KGaA during the 2nd quarter worth about $259,158,000. Finally, Korea Investment CORP acquired a new position in Merck KGaA during the 2nd quarter worth about $239,191,000. 0.10% of the stock is currently owned by institutional investors and hedge funds.
Merck KGaA Stock Performance
OTCMKTS MKGAF opened at $163.45 on Tuesday. The company has a market cap of $21.12 billion, a P/E ratio of 24.95 and a beta of 0.96. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The stock has a 50-day moving average of $162.78 and a two-hundred day moving average of $148.59. Merck KGaA has a 1-year low of $116.68 and a 1-year high of $175.56.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Further Reading
- Five stocks we like better than Merck KGaA
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
